Steward Partners Investment Advisory’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVGN
HF
XT
DSC
FDCDDQ
Steward Partners Investment Advisory's EVGN Position: Q2 2026 in Review
Steward Partners Investment Advisory sold out of Evogene (EVGN) in Q2 2026, closing a stake of 505 shares — an estimated $389 sold.
Steward Partners Investment Advisory first reported a position in EVGN in Q3 2020 and held it in 23 quarters. The position peaked at $25.2K in Q1 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.
- Steward Partners Investment Advisory reported no remaining Evogene position as of Q2 2026 after selling out during the quarter.
- Steward Partners Investment Advisory sold 505 Evogene shares in Q2 2026, an estimated $389.
- Steward Partners Investment Advisory first reported a position in Evogene in Q3 2020 and held it in 23 quarters.
- Steward Partners Investment Advisory's Evogene position peaked at $25.2K in Q1 2021.
- 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.